PEOPLE - Fujirebio Diagnostics makes appointment:
This article was originally published in Clinica
Fujirebio Diagnostics, developer and manufacturer of IVDs, specialising in tumour and marker assays, has appointed Monte Wiltse as vice-president of sales and marketing. Mr Wiltse will be responsible for executing the company's marketing plan and will assist in developing distributor relationships in order to launch the company's new biomarkers. Before joining the Malvern, Pennsylvania-based company, Mr Wiltse held senior marketing positions at Bayer Healthcare Diagnostics and, previously, UroCor.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.